Fig. 1 · Structure
Documents & Downloads
Mioflazine
Nucleoside Transport Inhibitor
Mioflazine is an orally active nucleoside transport inhibitor, primarily targeting nucleoside uptake mechanisms. It demonstrates significant cardiac protective properties, improving survival rates following global cardiac ischemia. Additionally, Mioflazine is noted for its sleep-enhancing effects and does not exert inotropic effects during administration. This compound is valuable for research in cardioprotective therapies and the modulation of sleep patterns.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 79467-23-5 |
| Applications | Nucleoside Transport Inhibitor |
| Formula | C29H30Cl2F2N4O2 |
| Molecular Weight | 575.48 |
| SMILES | O=C(NC1=C(Cl)C=CC=C1Cl)CN2CC(C(N)=O)N(CCCC(C3=CC=C(F)C=C3)C4=CC=C(F)C=C4)CC2 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.